Floundering Teva grabbed Allergan generics as a lifeline. It didn't work

3rd August 2017 Uncategorised 0

Back in January, when troubled Teva walked back its guidance by $1 billion-plus, some analysts worried the new numbers might still be too high. They were right.

More: Floundering Teva grabbed Allergan generics as a lifeline. It didn't work
Source: fierce